Georgios Imanidis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Georgios Imanidis has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Joerg Ogorka
Novartis Pharma AG, Basel, Switzerland
3 shared publicationsMarina Fanous
Novartis Pharma AG, Basel, Switzerland; Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland
3 shared publicationsMichael Lanz
School of Life Sciences, University of Applied Sciences Northwestern Switzerland, Muttenz, Basel, Switzerland
3 shared publicationsSarah Gold
Novartis Pharma AG, Basel, Switzerland
3 shared publicationsStefan Hirsch
Novartis Pharma AG, Basel, Switzerland
3 shared publicationsCharu Kochhar
Institute of Pharmaceutical Technology, University of Basel, Klingelbergstrasse 50, 4056, Switzerland
2 shared publications
Latest Publications
- Open Access
- 19 June 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 202, 114373
Formulation and dermal delivery of a new active pharmaceutical ingredient in an in vitro wound model for the treatment of chronic ulcers
- 19 June 2024
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 202, 114373
Open AccessFormulation and dermal delivery of a new active pharmaceutical ingredient in an in vitro wound model for the treatment of chronic ulcers
- Open Access
- 13 May 2023
- Published by Elsevier in Journal of Controlled Release
- Vol. 358, 420-438
Efficient colonic drug delivery in domestic pigs employing a tablet formulation with dual control concept
- 13 May 2023
- Published by Elsevier in Journal of Controlled Release
- Vol. 358, 420-438
Open AccessEfficient colonic drug delivery in domestic pigs employing a tablet formulation with dual control concept
- Open Access
- 15 December 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 631, 122499
Tablet formulation with dual control concept for efficient colonic drug delivery
- 15 December 2022
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 631, 122499
Open AccessTablet formulation with dual control concept for efficient colonic drug delivery
- Open Access
- 1 April 2021
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 599, 120417
Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution
- 1 April 2021
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 599, 120417
Open AccessDevelopment of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution
- 1 December 2020
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 155, 105558
Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance
- 1 December 2020
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 155, 105558
Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance
- 1 January 2020
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 146, 19-31
Production of fast-dissolving low-density powders for improved lung deposition by spray drying of a nanosuspension
- 1 January 2020
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 146, 19-31
Production of fast-dissolving low-density powders for improved lung deposition by spray drying of a nanosuspension
- 1 June 2016
- Published by Elsevier in Journal of Controlled Release
- Vol. 232, 248-254
Time controlled pulsatile transdermal delivery of nicotine: A phase I feasibility trial in male smokers
- 1 June 2016
- Published by Elsevier in Journal of Controlled Release
- Vol. 232, 248-254
Time controlled pulsatile transdermal delivery of nicotine: A phase I feasibility trial in male smokers
- 25 May 2016
- Published by Springer Nature
- Vol. 15 (7) , 861-871
Repartition of oil miscible and water soluble UV filters in an applied sunscreen film determined by confocal Raman microspectroscopy
Photoprotection provided by topical sunscreens is expressed by the sun protection factor (SPF) which depends primarily on the UV filters contained in the product and the applied sunscreen amount. Recently, the vehicle was shown to significantly impact film thickness distribution of an applied sunscreen and sunscreen efficacy. In the present work, repartition of the UV filters within the sunscreen film upon application is investigated for its role to affect sun protection efficacy. The spatial repartition of an oil-miscible and a water-soluble UV filter within the sunscreen film was studied using confocal Raman microspectroscopy. Epidermis of pig ear skin was used as substrate for application of three different sunscreen formulations, an oil-in-water emulsion, a water-in-oil emulsion, and a clear lipo-alcoholic spray (CAS) and SPF in vitro was measured. Considerable differences in the repartition of the UV filters upon application and evaporation of volatile ingredients were found between the tested formulations. A nearly continuous phase of lipid-miscible UV filter was formed only for the WO formulation with dispersed aggregates of water-soluble UV filter. OW emulsion and CAS exhibited interspersed patches of the two UV filters, whereas the segregated UV filter domains of the latter formulation were by comparison of a much larger scale and spanned the entire thickness of the sunscreen film. CAS therefore differed markedly from the other two formulations with respect to filter repartition. This difference should be reflected in SPF when the absorption spectra of the employed UV filters are not the same. Confocal Raman microspectroscopy was shown to be a powerful technique for studying this mechanism of sun protection performance of sunscreens.
- 25 May 2016
- Published by Springer Nature
- Vol. 15 (7) , 861-871
Repartition of oil miscible and water soluble UV filters in an applied sunscreen film determined by confocal Raman microspectroscopy
Photoprotection provided by topical sunscreens is expressed by the sun protection factor (SPF) which depends primarily on the UV filters contained in the product and the applied sunscreen amount. Recently, the vehicle was shown to significantly impact film thickness distribution of an applied sunscreen and sunscreen efficacy. In the present work, repartition of the UV filters within the sunscreen film upon application is investigated for its role to affect sun protection efficacy. The spatial repartition of an oil-miscible and a water-soluble UV filter within the sunscreen film was studied using confocal Raman microspectroscopy. Epidermis of pig ear skin was used as substrate for application of three different sunscreen formulations, an oil-in-water emulsion, a water-in-oil emulsion, and a clear lipo-alcoholic spray (CAS) and SPF in vitro was measured. Considerable differences in the repartition of the UV filters upon application and evaporation of volatile ingredients were found between the tested formulations. A nearly continuous phase of lipid-miscible UV filter was formed only for the WO formulation with dispersed aggregates of water-soluble UV filter. OW emulsion and CAS exhibited interspersed patches of the two UV filters, whereas the segregated UV filter domains of the latter formulation were by comparison of a much larger scale and spanned the entire thickness of the sunscreen film. CAS therefore differed markedly from the other two formulations with respect to filter repartition. This difference should be reflected in SPF when the absorption spectra of the employed UV filters are not the same. Confocal Raman microspectroscopy was shown to be a powerful technique for studying this mechanism of sun protection performance of sunscreens.